A team of psychiatric providers & clinicians at one outpatient site in Chico, California working collaboratively to help people with behavioral health issues get better.
Esketamine, or Spravato®, is the first nasal spray medication that is a treatment for depression. Combined with an antidepressant, Spravato® is FDA-approved to treat depression and has been clinically shown to improve symptoms of depression over just 4 weeks.
Dr. Kullar, Child and Adolescent Psychiatrist, begins at Therapeutic Solutions in September and will start seeing patients – ages 4 to 24 – on September 8th.
Patients should contact our office regarding insurance coverage options.